Investor Presentaiton slide image

Investor Presentaiton

Formulations : Sustaining growth momentum. Key Updates EUROPE- Return to growth with launch of new Phyto range. Structural adjustments to improve margins Manufacturing in Germany discontinued and operations to shift to alternative low cost locations. Margin accretive from Q3 FY 24 EMERGING MARKETS - Nourrie integration completed in Brazil. New platform created for companion animals. Turkey business impacted by inflationary pressures and the recent earthquake. INDIA- Cattle business continues to grow by ~10% despite challenges in rural markets. Expansion of team for accelerated growth in FY 24 1,878 6,789 2,451 Revenues 14% 9,686 8,824 2,494 J Sequent Proven Ability In Life Sciences ALIVIRA FDFs 1000+ Manufacturing facilities 6 All values in * Mn R&D Centres 4 2,559 10,009 Q4 FY20 FY20 Q4 FY21 FY21 Q4 FY22 FY22 Q4 FY23 FY23 cc- Constant Currency Countries with marketing 80+ presence 6
View entire presentation